AESTHETICS

1. Treating the “Aesthetic Cost” of GLP-1s (Ozempic Face & Body)

The explosive, widespread use of GLP-1 receptor agonists (like Ozempic, Wegovy, and Mounjaro) has fundamentally altered plastic surgery and dermatology clinic workflows. Because the associated weight loss is rapid and massive, patients are presenting with deflated, sagging skin that has not had time to contract naturally. [1, 2, 3]

• The Structural Rebound: This phenomenon has triggered a major surge in structural surgeries rather than relying on heavy temporary fillers. Clinicians report a massive spike in deep plane facelifts to reposition dropped tissues, alongside high demand for standalone neck lifts and comprehensive breast lifts. [1, 2, 3, 4, 5]
• Fat Over Fillers: To combat “Ozempic face,” surgeons are heavily prioritizing facial fat grafting (using a patient’s own fat cells) over traditional hyaluronic acid fillers to build back healthy, long-lasting structural volume. [1, 2, 3]

2. The Regenerative Revolution Over Volumisation

The single biggest philosophical shift is the transition from “filling a gap” to making the skin physically work harder. Overdone dermal filler is officially declining, replaced by bio-stimulation and regenerative add-ons: [1, 2, 3, 4, 5]

• Polynucleotides and Exosomes: These cellular messengers, derived from salmon DNA or cellular cultures, are being injected directly into the skin to repair damaged cells, induce natural collagen, and drastically improve skin elasticity. [1, 2, 3, 4, 5]
• Biostimulators: Non-hyaluronic injectables that prompt the body to grow its own structural tissue are dominating the market, driving significant year-on-year growth in the regenerative category. [1, 2]

3. “High-Fidelity” Work and Treatment Stacking

Patients are demanding completely undetectable results that prioritize “quiet luxury” and natural anatomy over artificial transformation. [1, 2]

• The Death of Single-Fix Appointments: Leading clinics are entirely abandoning single-modality treatments. Instead, they rely on Treatment Stacking, combining subtle low-dose neuromodulators (prejuvenation), micro-fillers, and advanced laser coring within a single comprehensive treatment ecosystem.
• The Non-Surgical Skepticism Rebound: Interestingly, public sentiment has begun to push back against over-hyped energy-based skin tightening devices and thread lifts. Patients are openly sharing limitations regarding underperforming non-surgical tools. The narrative has shifted from trying to avoid surgery at all costs to recognizing exactly when non-surgical options fail and when an early, precise surgical lift is more effective. [1, 2, 3, 4, 5]

4. AI Personalisation and Digital “Before & After” Scrutiny

Technology has changed both the consultation room and how patients judge aesthetic ethics: [1, 2, 3, 4]

• AI-Enhanced Selves: Rather than bringing photos of celebrities to consultations, patients are now bringing AI-altered images of themselves generated via editing apps, presenting a brand-new challenge for managing surgical expectations.
• The “Before & After” Crackdown: There is a heavy industry pushback against edited clinical photos. Regulatory bodies are intensifying scrutiny over providers who use misleading lighting, blemish smoothing, and specific camera angles to fake non-surgical results, driving patients to demand higher transparency and strict medical board credentials before booking.